News

AddToAny

Google+ Facebook Twitter Twitter

"Disasters lead to reductions in cancer screening"

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011.

Tohoku University’s Yasuhiro Miki, who specialises in disaster obstetrics and gynaecology, was one of the scientists researching the issue.

He said: “Conflicts and disasters, and the social isolation that often follows, have a major impact on healthcare and lead to delays in the diagnosis and treatment of cancers.”

On 11 March 2011, Miyagi Prefecture in eastern Japan experienced a 9.0 magnitude earthquake, followed by a destructive tsunami that affected its coastal areas.

Miki and colleagues examined how the earthquake affected cervical cancer screening rates in the area.

In the five years after the 2011 disaster, cervical cancer screenings dropped by more than 3% in four areas of Miyagi Prefecture.

Across Japan, approximately 15 women per 100,000 people are affected by cervical cancer.

This rate is higher than that in countries such as the US (6.5) and South Korea (8.4), and similar to that in India (14.7) and the Philippines (14.9).

Also, fewer than 1% of girls in Japan have received the human papillomavirus vaccine, which protects against cervical cancer.

This means that cervical cancer screening is of particular importance for early detection and diagnosis.

Even so, cervical cancer screening rates are lower in Japan compared to other countries, such as the UK.  

bit.ly/2woRmW8

 
Picture Credit | iStock

 

Related Articles

My lab: a whole new approach to assessment

Leslie Ramos, Cellular Pathology Quality Manager, gives a guided tour of her lab and talks through a recent virtual UKAS assessment.

Sponge on a string pill

A “sponge on a string” pill test can identify 10 times more people with Barrett’s oesophagus than the usual GP route, finds new research.

Here to help: New cytology portfolios

This month we are outlining a new launch to better support the training and development of the biomedical scientist workforce.

Cervical screening in Moldova

Lead Biomedical Scientist and British Association for Cytopathology Executive Committee Member Hedley Glencross introduces a project to improve the outdated cervical screening programme in the Republic of Moldova.

Top